COVID-19: Toxicities of Potential Therapies

May 13, 2020 00:21:18
COVID-19: Toxicities of Potential Therapies
Critical Care Perspectives in Emergency Medicine
COVID-19: Toxicities of Potential Therapies
/

Show Notes

Currently, there is no approved treatment or proven therapy for COVID-19. As such, many have turned to treatments with little to no supporting evidence. In this podcast, we bring back EM Pharmacy extraordinaire Bryan Hayes to discuss information on the toxicities of potential therapies used in the management of patients with COVID-19.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Episode Transcript

No transcript available...

Other Episodes

Episode

November 17, 2017 00:27:56
Episode Cover

Mechanical Circulatory Support Devices

What do you do for the patient in cardiogenic shock who is not responding to vasopressors and inotropes?  Should you place a mechanical circulatory support device as a bridge to PCI or CABG? We discuss the pearls and pitfalls of the latest devices. Download Companion HandoutDownload You can get CME credit for this episode here ...

Listen

Episode

March 19, 2019 00:18:13
Episode Cover

BMV for ETI in the Critically Ill?

More than 1.5 million patients undergo endotracheal intubation each year in the U.S.  Endotracheal intubation can be complicated by hypoxemia, which is a known risk factor for peri-intubation cardiac arrest and death.  Rapid sequence intubation typically involves a delay of up to 2 minutes between the administration of sedative/paralytic medications and laryngoscopy.  In this podcast, we discuss a recent article in the New England Journal of Medicine that suggests critically ill patients may benefit from bag-mask ventilation during the period between medication administration and laryngoscopy.  Download Companion HandoutDownload You can get CME credit for this episode here! Click here for CME Account Creation Instructions ...

Listen

Episode

February 18, 2020 00:19:11
Episode Cover

Roc vs. Sux - The CURASMUR Trial

The debate on the ideal neuromuscular blocking agent for RSI in emergency intubations rages on. In this podcast, we review the latest randomized trial comparing rocuronium with succinylcholine in out-of-hospital patients needing emergency tracheal intubation – The CURASMUR Trial. Emergency medicine airway guru Dr. Ken Butler takes us through the paper and provides his expert opinion on which NMBA you should be reaching for in your next intubation! Download Companion Handout Download You can get CME credit for this episode here!Click here for CME Account Creation Instructions ...

Listen